MENU
CMMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Chemomab Therapeutics (CMMB) Ownership - Who owns Chemomab Therapeutics?

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10 Habarzel Street
Phone
+972 773310156
Employees
10
Web
https://www.chemomab.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.96M
P/E Ratio
N/A
Total Cash
8.04M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.56
Dividend Yield
N/A
Total Cash/Share
1.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
CMMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
10 Habarzel Street
Phone
+972 773310156
Employees
10
Web
https://www.chemomab.com